Search Results
208 results
Your search is now limited to «Bladder Cancer» expert search.
Top Class Actions 03/19/2019 07:00
Actos Drug Lawsuit Alleges Takeda Failed to Warn About Bladder Cancer.
More from Top Class Actions: 03/19/2019 03:40
Photocure ASA: Hexvix® /Cysview® with Flexible Cystoscopy improves Bladder Cancer detection. Data presented at the EAU congress in Barcelona. 19.03.2019 08:00 Oslo, Norway March 19, 2019, Photocure ASA (PHO:OSE), is pleased to announce that Blue Light Cystoscopy (BLCT) with Hexvix® was presented at the European Association of Urology (EAU) congress held in Barcelona, Spain, March 15th -18th. The EAU annual meeting is one of the largest international meetings in the urology calendar, showcasing the latest and most relevant knowledge in urology with more than 14,000 urologists and exhibitors from over 110 countries. Dr. Yair Lotan, M.D., Professor of...
More from
Business Wire 03/18/2019 07:05
This program provides an opportunity for us to collaborate with Dr. Fradet’s team and other experts in the bladder cancer field to advance a potential new candidate for the many patients whose current treatment options are limited.
More from Business Wire: 03/15/2019 03:59
New study finds that experiencing menopause before the age of 45 is linked to a higher risk of bladder cancer.
More from
PubMed News (NIH) 03/14/2019
A TCGA cohort of 408 muscle-invasive bladder cancers was used as a reference cohort.
More from PubMed News (NIH): 03/06/2019 09:23
... of this project is to validate and develop a simulator-based urological training programme in TURB, to implement the programme nationally and internationally, and hereby improve the outcomes in the surgical treatment of patients with bladder cancer.
More from
There are currently no effective treatment targets for the more than 18,000 bladder cancer patients diagnosed every year in the UK,' said Andrew Winterbottom, founder of Fight Bladder Cancer.
More from Mail on Sunday (United Kingdom):
A meta-analysis of the efficacy and safety of PD-1/PD-L1 immune checkpoint inhibitors as treatments for metastatic bladder cancer Zhongyuan Fan,1,* Ye Liang,1,* Xuecheng Yang,1 Bin Li,1 Lili Cui,2 Lei Luo,1 Yuefeng Jia,1 Yonghua Wang,1 Haitao Niu1 1Department of Urology, The Affiliated Hospital of Qingdao University, Qingdao, China; 2Department of Urology, Dongying Vocational Institute, Dongying, China *These authors contributed equally to this work Background: This article is a meta-analysis aiming to systematically assess the efficacy and safety profiles of PD-1/PD-L1 inhibitors in patients with advanced or metastatic bladder cancer.Methods: We extracted and examined data from phase I, II, and III clinical trials from the Medline, Embase,
More from International Journal of COPD:
Journal of Clinical Oncology, Ahead of Print.
More from American Society of Clinical Oncolgy (ASCO):

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors


Diagnostics and Therapeutics


Drugs - Brand Names

Drugs - Generic



Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices



Strategic Scenarios



On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 

  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications